The association between circulating 25-hydroxyvitamin D and cardiovascular diseases: a meta-analysis of prospective cohort studies

[1]  C. Marcocci,et al.  Controversies in Vitamin D: Summary Statement From an International Conference , 2018, The Journal of clinical endocrinology and metabolism.

[2]  V. Gudnason,et al.  Effects of vitamin D supplementation on markers for cardiovascular disease and type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials. , 2018, The American journal of clinical nutrition.

[3]  J. Brent Richards,et al.  Mendelian Randomization Studies Do Not Support a Role for Vitamin D in Coronary Artery Disease , 2016, Circulation. Cardiovascular genetics.

[4]  W. März,et al.  Vitamin D and cardiovascular disease prevention , 2016, Nature Reviews Cardiology.

[5]  D. Papandreou,et al.  The Role of Vitamin D in Diabetes and Cardiovascular Disease: An Updated Review of the Literature , 2015, Disease markers.

[6]  A. Sposito,et al.  Vitamin D for the prevention of cardiovascular disease: Are we ready for that? , 2015, Atherosclerosis.

[7]  I. Mozoș,et al.  Links between Vitamin D Deficiency and Cardiovascular Diseases , 2015, BioMed research international.

[8]  Shoaib Afzal,et al.  No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study. , 2015, International journal of epidemiology.

[9]  N. Wareham,et al.  Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: a 13-y prospective population study , 2014, The American journal of clinical nutrition.

[10]  R. Ravindrarajah,et al.  Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men. , 2014, Age and ageing.

[11]  O. Franco,et al.  Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies , 2014, BMJ : British Medical Journal.

[12]  E. Barrett-Connor,et al.  Circulating vitamin D, supplement use, and cardiovascular disease risk: the MrOS Sleep Study. , 2014, The Journal of clinical endocrinology and metabolism.

[13]  J. Wetterslev,et al.  Vitamin D supplementation for prevention of mortality in adults. , 2011, The Cochrane database of systematic reviews.

[14]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[15]  P. Autier,et al.  Vitamin D status and ill health: a systematic review. , 2014, The lancet. Diabetes & endocrinology.

[16]  B. Schöttker,et al.  Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: a prospective study with repeated measurements. , 2013, The Journal of clinical endocrinology and metabolism.

[17]  Stefan Pilz,et al.  Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. , 2013, Autoimmunity reviews.

[18]  H. Boeing,et al.  Plasma 25-Hydroxyvitamin D and Its Genetic Determinants in Relation to Incident Myocardial Infarction and Stroke in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany Study , 2013, PloS one.

[19]  F. Formiga,et al.  Low Serum Vitamin D is Not Associated with an Increase in Mortality in Oldest Old Subjects: The Octabaix Three-Year Follow-Up Study , 2013, Gerontology.

[20]  H. Brenner,et al.  Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. , 2013, The American journal of clinical nutrition.

[21]  H. Brenner,et al.  Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies , 2013, Ageing Research Reviews.

[22]  B. Nordestgaard,et al.  25‐Hydroxyvitamin D and symptomatic ischemic stroke: An Original Study and Meta‐Analysis , 2013, Annals of neurology.

[23]  A. Peters,et al.  Low levels of serum 25-hydroxyvitamin D are associated with increased risk of myocardial infarction, especially in women: results from the MONICA/KORA Augsburg case-cohort study. , 2013, The Journal of clinical endocrinology and metabolism.

[24]  J. Manson,et al.  Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study , 2012, Osteoporosis International.

[25]  J. Manson,et al.  Circulating 25-Hydroxy-Vitamin D and Risk of Cardiovascular Disease: A Meta-Analysis of Prospective Studies , 2012, Circulation. Cardiovascular quality and outcomes.

[26]  N. Sattar,et al.  Circulating 25OHD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: the MIDSPAN Family Study. , 2012, The Journal of clinical endocrinology and metabolism.

[27]  E. Barrett-Connor,et al.  Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. , 2012, NMCD. Nutrition Metabolism and Cardiovascular Diseases.

[28]  Longjian Liu,et al.  Serum 25-hydroxyvitamin D concentration and mortality from heart failure and cardiovascular disease, and premature mortality from all-cause in United States adults. , 2012, The American journal of cardiology.

[29]  S. Rubin,et al.  25-Hydroxyvitamin D, parathyroid hormone, and mortality in black and white older adults: the health ABC study. , 2012, The Journal of clinical endocrinology and metabolism.

[30]  W. Willett,et al.  A pooled analysis of vitamin D dose requirements for fracture prevention. , 2012, The New England journal of medicine.

[31]  B. Kestenbaum,et al.  Serum 25-Hydroxyvitamin D Concentration and Risk for Major Clinical Disease Events in a Community-Based Population of Older Adults , 2012, Annals of Internal Medicine.

[32]  R. Luben,et al.  Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies , 2012, Diabetologia.

[33]  H. Bischoff-Ferrari.  Vitamin D and fracture prevention. , 2012, Rheumatic diseases clinics of North America.

[34]  C. Cooper,et al.  Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). , 2012, The Journal of clinical endocrinology and metabolism.

[35]  S. Pilz,et al.  Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. , 2012, The American journal of clinical nutrition.

[36]  Jennifer G. Robinson,et al.  Prospective association of vitamin D concentrations with mortality in postmenopausal women: results from the Women's Health Initiative (WHI). , 2011, The American journal of clinical nutrition.

[37]  B. Kestenbaum,et al.  Vitamin D, parathyroid hormone, and cardiovascular events among older adults. , 2011, Journal of the American College of Cardiology.

[38]  A. LaCroix,et al.  The Effect of Calcium plus Vitamin D on Risk for Invasive Cancer: Results of the Women's Health Initiative (WHI) Calcium Plus Vitamin D Randomized Clinical Trial , 2011, Nutrition and cancer.

[39]  J. Mursu,et al.  Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland , 2011, European journal of nutrition.

[40]  M. Melamed,et al.  Vitamin D Status and Risk of Cardiovascular Events: Lessons Learned via Systematic Review and Meta-Analysis , 2011, Cardiology in review.

[41]  A. Khera,et al.  Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement From the American Heart Association , 2011, Circulation.

[42]  JoAnn E. Manson,et al.  The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.

[43]  A. Alwan.  Global status report on noncommunicable diseases 2010. , 2011 .

[44]  B. Norrving,et al.  Global atlas on cardiovascular disease prevention and control. , 2011 .

[45]  W. März,et al.  Vitamin D supplementation: a promising approach for the prevention and treatment of strokes. , 2011, Current drug targets.

[46]  E. Barrett-Connor,et al.  Vitamin d, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study. , 2010, The American journal of medicine.

[47]  B. Horne,et al.  Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. , 2010, The American journal of cardiology.

[48]  L. Holmberg,et al.  Plasma vitamin D and mortality in older men: a community-based prospective cohort study. , 2010, The American journal of clinical nutrition.

[49]  S. Cummings,et al.  Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. , 2010, The Journal of clinical endocrinology and metabolism.

[50]  H. Brenner,et al.  Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. , 2010, Preventive medicine.

[51]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[52]  R. Jorde,et al.  Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study. , 2010, European journal of endocrinology.

[53]  J. Manson,et al.  Systematic Review: Vitamin D and Calcium Supplementation in Prevention of Cardiovascular Events , 2010, Annals of Internal Medicine.

[54]  25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services , 2010, Neurology.

[55]  Kevin Fiscella,et al.  Vitamin D, Race, and Cardiovascular Mortality: Findings From a National US Sample , 2010, The Annals of Family Medicine.

[56]  S. Bandinelli,et al.  Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults , 2009, European Journal of Clinical Nutrition.

[57]  I. Reid,et al.  Vitamin D insufficiency and health outcomes over 5 y in older women. , 2010, The American journal of clinical nutrition.

[58]  G. Nijpels,et al.  Vitamin D and mortality in older men and women , 2009, Clinical endocrinology.

[59]  Markku Heliövaara,et al.  American Journal of Epidemiology Original Contribution Vitamin D Status and the Risk of Cardiovascular Disease Death , 2022 .

[60]  D. Moher,et al.  Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Physical therapy.

[61]  Carlos A Camargo,et al.  Prospective Study of Serum 25‐Hydroxyvitamin D Level, Cardiovascular Disease Mortality, and All‐Cause Mortality in Older U.S. Adults , 2009, Journal of the American Geriatrics Society.

[62]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[63]  S. Mohr,et al.  Vitamin D for cancer prevention: global perspective. , 2009, Annals of epidemiology.

[64]  A. Norman.  A vitamin D nutritional cornucopia: new insights concerning the serum 25-hydroxyvitamin D status of the US population. , 2008, The American journal of clinical nutrition.

[65]  Elizabeth A Yetley,et al.  Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. , 2008, The American journal of clinical nutrition.

[66]  Gert B. M. Mensink,et al.  Vitamin D status and health correlates among German adults , 2008, European Journal of Clinical Nutrition.

[67]  W. März,et al.  Low Vitamin D Levels Predict Stroke in Patients Referred to Coronary Angiography , 2008, Stroke.

[68]  B. Astor,et al.  25-hydroxyvitamin D levels and the risk of mortality in the general population. , 2008, Archives of internal medicine.

[69]  Stefan Pilz,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[70]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[71]  C. Mathieu,et al.  Vitamin D and human health: lessons from vitamin D receptor null mice. , 2008, Endocrine reviews.

[72]  K. Zhu,et al.  Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. , 2008, Archives of internal medicine.

[73]  P. Tseke,et al.  Vitamin D, the renin-angiotensin system, and insulin resistance , 2008, International Urology and Nephrology.

[74]  Sara Gandini,et al.  Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.

[75]  Y. Shoenfeld,et al.  Vitamin D and autoimmunity: new aetiological and therapeutic considerations , 2007, Annals of the rheumatic diseases.

[76]  Zhenqi Liu.  The renin-angiotensin system and insulin resistance , 2007, Current diabetes reports.

[77]  P. Lips,et al.  13th Workshop consensus for vitamin D nutritional guidelines , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[78]  E. Grossi.  BMC Cardiovascular Disorders , 2007 .

[79]  W. Willett,et al.  Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.

[80]  A. Sutton,et al.  Comparison of two methods to detect publication bias in meta-analysis. , 2006, JAMA.

[81]  Julian P T Higgins,et al.  Controlling the risk of spurious findings from meta‐regression , 2004, Statistics in medicine.

[82]  Guilin Qiao,et al.  Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[83]  P. Lips.  Which circulating level of 25-hydroxyvitamin D is appropriate? , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[84]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[85]  E. Wolf,et al.  Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[86]  R. Doll,et al.  Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial , 2003, BMJ : British Medical Journal.

[87]  D. Bereczki,et al.  The Cochrane Database of Systematic Reviews , 2003 .

[88]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[89]  H. Koeffler,et al.  Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. , 2002, The Journal of clinical investigation.

[90]  H. DeLuca,et al.  Vitamin D: its role and uses in immunology 1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[91]  J. Sterne,et al.  Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. , 2000, Journal of clinical epidemiology.

[92]  A. Tobías.  Assessing the influence of a single study in the meta-anyalysis estimate , 1999 .

[93]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[94]  E. Maccarthy,et al.  1,25‐Dihydroxyvitamin D3 and Rat Vascular Smooth Muscle Cell Growth , 1989, Hypertension.

[95]  G. Grodsky,et al.  Vitamin D deficiency inhibits pancreatic secretion of insulin. , 1980, Science.